Thomas K. Equels, CEO, President at HEMISPHERX BIOPHARMA INC (HEB), bought 144,928 shares at $0.69 ($100K) on 2017-04-27, disclosed to the SEC on 2017-04-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 72,464 | $50K | 50.0% |
| 2 | $0.69 | 72,464 | $50K | 50.0% |
| Total | $0.69 avg | 144,928 | $100K | 100% |
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |